- Home
- RNW vs PTGX Comparison
RNW vs PTGX Comparison
Compare RNW & PTGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RNW | PTGX |
|---|---|---|
| Founded | 2011 | 2006 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Electric Utilities: Central | Biotechnology: Pharmaceutical Preparations |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.7B | 5.4B |
| IPO Year | N/A | 2016 |
Fundamental Metrics
Financial Performance| Metric | RNW | PTGX |
|---|---|---|
| Price | $5.71 | $81.96 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 9 |
| Target Price | $7.25 | ★ $93.00 |
| AVG Volume (30 Days) | ★ 2.1M | 909.6K |
| Earning Date | 02-17-2026 | 02-20-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 413.66 | N/A |
| EPS | 0.26 | ★ 0.72 |
| Revenue | ★ $1,382,164,625.00 | $209,217,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $17.07 | $288.98 |
| P/E Ratio | ★ $21.87 | $114.23 |
| Revenue Growth | ★ 46.76 | N/A |
| 52 Week Low | $5.05 | $33.70 |
| 52 Week High | $8.24 | $96.54 |
Technical Indicators
Market Signals| Indicator | RNW | PTGX |
|---|---|---|
| Relative Strength Index (RSI) | 34.70 | 36.66 |
| Support Level | $5.05 | $84.11 |
| Resistance Level | $5.89 | $89.61 |
| Average True Range (ATR) | 0.21 | 3.19 |
| MACD | 0.05 | -1.01 |
| Stochastic Oscillator | 79.88 | 3.89 |
Price Performance
Historical ComparisonAbout RNW ReNew Energy Global plc
ReNew Energy Global PLC is a developer and operator of clean energy projects intended to meet India's growing energy needs in an efficient, sustainable and socially responsible manner. The company provides end-to-end solutions in a just and inclusive manner in the areas of clean energy, value-added energy offerings through digitalization, storage, and carbon markets that increasingly are integral to addressing climate change. The company has four reportable segments: wind power and solar power, hydro power and transmission line. It derives maximum revenue from Wind Power segment.
About PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.